PGNY News and Press, Progyny Inc. From 05/24/22

NEW YORK, May 24, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced the expansion of its leadership team. Arielle Bogorad, formerly from Cerner C...

Polen Capital is a high-conviction growth investment manager. We scour the globe in search of the highest quality, sustainable companies to invest in. A broad-based selling of risk assets, high correlations and a preference for the types of companies that typically do not meet our inv...

Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. The market was very weak in the quarter for a plethora of reasons. The Fed is in a tough position, as it needs to sig...

NEW YORK, May 06, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, and The Broken Brown Egg, a nonprofit supporting BIPOC individuals and couples experiencing i...

Progyny, Inc. (PGNY) Q1 2022 Earnings Call Transcript May 5, 2022 05:00 p.m. ET Company Representatives Peter Anevski - Chief Executive Officer Michael Sturmer - President Mark Livingston - Chief Financial Officer James Hart - Vice President of Investor Relations Conference Call Participants ...

Progyny press release (NASDAQ:PGNY): Q1 GAAP EPS of $0.05 beats by $0.03. Revenue of $172.2M (+41.0% Y/Y) beats by $5.02M.Issues 2022 Guidance: Revenue Guidance of $188.0 to $193.0 Million ($189.03M consensus) for the Second Quarter, Reflecting Growth of 46% to 50% For further details see: ...

Reports Record Revenue of $172.2 Million, Reflecting 41% Growth Over the Prior Year Period Raises Lower End of Full Year 2022 Guidance Ranges Issues Revenue Guidance of $188.0 to $193.0 Million for the Second Quarter, Reflecting Growth of 46% to 50% Early Season Sales Activity Affirms...

Progyny (NASDAQ:PGNY) is scheduled to announce Q1 earnings results on Thursday, May 5th, after market close. The consensus EPS Estimate is -$0.02 (vs. $0.15 in prior year) and the consensus Revenue Estimate is $167.18M (+36.9% Y/Y). Over the last 1 year, PGNY has beaten EPS estimates 75%...

NEW YORK, April 28, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced executives from Progyny will participate in a fireside chat at the BofA Sec...

NEW YORK, April 21, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, will report its financial results for the quarterly period ended March 31, 2022 after the c...